The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

E•••••• L••

Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: Healthcare & Pharmaceuticals
See every lender's markFind rescue capital
More
Special situations PE firms

What matters now

  1. 101¢ → 97¢
    consensus mark

    Consensus mark 97¢ on cost, down from 101¢ a year ago, 99¢ last quarter.

    Q2 2026 · The lenders' own valuations, the most direct read of what they expect to recover.

    Derived2 of 2 lenders' own marks, weighted by principal
Mark path, consensus per quarter end
Q2 2025: 101¢Q3 2025: 101¢Q4 2025: 100¢Q1 2026: 99¢Q2 2026: 97¢101¢ · 101¢ · 100¢ · 99¢ · 97¢Q2 2025 to Q2 2026
Where each lender marks it, 0 points apart
97¢Consensus: 97¢C•••••• S•••••• L••••••• I•••: 97¢C•••••• C••••• S••••••••• I•••: 97¢97¢
Principal held
at least $71.3M
sum of BDC pieces, a lower bound
Fair value
$68.4M
97c on cost, debt pieces
Unfunded
$4.9M
commitments not yet drawn
BDC lenders
7
2 on the latest quarter
Facilities
3
0 equity pieces beside them
Next maturity
Sep 14, 2030
no dated debt inside 24 months
On the tape since
Dec 31, 2021
latest Jun 30, 2026
Events
15
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
LenderExposureCurrent markQoQ change
C•••••• S•••••• L••••••• I•••$35.7M97¢-2 pts
C•••••• C••••• S••••••••• I•••$35.7M97¢-2 pts
Every BDC piece · 4 positions across 2 lenderslargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
C•••••• S•••••• L••••••• I•••term loan first lien
Investment | N••••••••• I••••• | F•••• L••• D•••
$35.7M$34.2M
97c
S+300 bp
PIK 3.50%
C•••••• C••••• S••••••••• I•••term loan first lien
Investment | N••••••••• I••••• | F•••• L••• D•••
$35.7M$34.2M
97c
S+300 bp
PIK 3.50%
C•••••• C••••• S••••••••• I•••revolver second lien
Investments | N••••••••• I••••• | F•••• and S••••• L••• D••• | R•••••••
Not disclosedNot disclosed
C•••••• S•••••• L••••••• I•••revolver second lien
Investments | N••••••••• | F•••• and S••••• L••• D••• | R•••••••
Not disclosedNot disclosed
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $71.3M97cS+300 bp
PIK 3.50%
Sep 14, 20302
second lien revolver second lienunknownn/aunstated2
first lien revolver first lien
exited Mar 31, 2025
at least $722,00073c//www.stonepoint.com/20250331#Alternate Base Rate+750 bpSep 14, 20271
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20262$71.3M$68.4M97c2
Mar 31, 20262$70.5M$68.9M99c2
Dec 31, 20252$69.9M$69.4M100c2
Sep 30, 20252$75.3M$75.6M101c2
All 17 quarters
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20252$74.6M$74.7M101c0
Mar 31, 20256$72.2M$65.3M91c3
Dec 31, 20246$152M$132M88c11
Sep 30, 20247$70.6M$60.0M86c6
Jun 30, 20247$70.4M$58.7M85c6
Mar 31, 20247$70.3M$59.5M86c6
Dec 31, 20237$113M$96.0M86c0
Sep 30, 20237$70.6M$64.9M93c0
Jun 30, 20237$70.8M$64.4M92c0
Mar 31, 20237$71.0M$68.8M99c0
Dec 31, 20227$94.8M$91.9M99c0
Sep 30, 20222$19.1M$18.0M96c0
Dec 31, 20212$19.2M$18.8M100c0
What changed
Full timeline · 30 events
Every change including routine ones
Identity
Group key
ELLKAYderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 7 BDCsderived
Industry
Healthcare & Pharmaceuticalsreportedas one filer wrote it